Isis Pharmaceuticals' (ISIS) Ibis Wins Contract for Up to $8.4M in New Government Grants for Pathogen Detection and Human Forensics
Tweet Send to a Friend
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that its majority-owned subsidiary, Ibis Biosciences, Inc., was awarded government grants and contracts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
